Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Atazanavir | Magnesium peroxide can cause a decrease in the absorption of Atazanavir resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Bosutinib | Magnesium peroxide can cause a decrease in the absorption of Bosutinib resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Cefditoren | The serum concentration of Cefditoren can be decreased when it is combined with Magnesium peroxide. |
| Dabigatran etexilate | Magnesium peroxide can cause a decrease in the absorption of Dabigatran etexilate resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Dabrafenib | Magnesium peroxide can cause a decrease in the absorption of Dabrafenib resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Dasatinib | Magnesium peroxide can cause a decrease in the absorption of Dasatinib resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Delavirdine | Magnesium peroxide can cause a decrease in the absorption of Delavirdine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Erlotinib | Magnesium peroxide can cause a decrease in the absorption of Erlotinib resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Gefitinib | Magnesium peroxide can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Itraconazole | Magnesium peroxide can cause a decrease in the absorption of Itraconazole resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Ledipasvir | Magnesium peroxide can cause a decrease in the absorption of Ledipasvir resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Methylphenidate | Magnesium peroxide can cause an increase in the absorption of Methylphenidate resulting in an increased serum concentration and potentially a worsening of adverse effects. |
| Pazopanib | Magnesium peroxide can cause a decrease in the absorption of Pazopanib resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Riociguat | Magnesium peroxide can cause a decrease in the absorption of Riociguat resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Calcitriol | The serum concentration of Magnesium peroxide can be increased when it is combined with Calcitriol. |
| Calcifediol | The serum concentration of Magnesium peroxide can be increased when it is combined with Calcifediol. |
| Ergocalciferol | The serum concentration of Magnesium peroxide can be increased when it is combined with Ergocalciferol. |
| Cholecalciferol | The serum concentration of Magnesium peroxide can be increased when it is combined with Cholecalciferol. |
| Paricalcitol | The serum concentration of Magnesium peroxide can be increased when it is combined with Paricalcitol. |
| Dihydrotachysterol | The serum concentration of Magnesium peroxide can be increased when it is combined with Dihydrotachysterol. |
| Alfacalcidol | The serum concentration of Magnesium peroxide can be increased when it is combined with Alfacalcidol. |
| Seocalcitol | The serum concentration of Magnesium peroxide can be increased when it is combined with Seocalcitol. |
| Inecalcitol | The serum concentration of Magnesium peroxide can be increased when it is combined with Inecalcitol. |
| Becocalcidiol | The serum concentration of Magnesium peroxide can be increased when it is combined with Becocalcidiol. |
| Eldecalcitol | The serum concentration of Magnesium peroxide can be increased when it is combined with Eldecalcitol. |
| 1alpha,24S-Dihydroxyvitamin D2 | The serum concentration of Magnesium peroxide can be increased when it is combined with 1alpha,24S-Dihydroxyvitamin D2. |
| Elocalcitol | The serum concentration of Magnesium peroxide can be increased when it is combined with Elocalcitol. |
| Maxacalcitol | The serum concentration of Magnesium peroxide can be increased when it is combined with Maxacalcitol. |
| Doxercalciferol | The serum concentration of Magnesium peroxide can be increased when it is combined with Doxercalciferol. |
| Vitamin D | The serum concentration of Magnesium peroxide can be increased when it is combined with Vitamin D. |
| 1alpha-Hydroxyvitamin D5 | The serum concentration of Magnesium peroxide can be increased when it is combined with 1alpha-Hydroxyvitamin D5. |
| Previtamin D(3) | The serum concentration of Magnesium peroxide can be increased when it is combined with Previtamin D(3). |
| Deferiprone | Magnesium peroxide can cause a decrease in the absorption of Deferiprone resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Dolutegravir | Magnesium peroxide can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Eltrombopag | Magnesium peroxide can cause a decrease in the absorption of Eltrombopag resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Levothyroxine | Magnesium peroxide can cause a decrease in the absorption of Levothyroxine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Tolevamer | The risk or severity of adverse effects can be increased when Tolevamer is combined with Magnesium peroxide. |
| Bisacodyl | The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Magnesium peroxide. |
| Captopril | Magnesium peroxide can cause a decrease in the absorption of Captopril resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Cefpodoxime | The serum concentration of Cefpodoxime can be decreased when it is combined with Magnesium peroxide. |
| Cefuroxime | The serum concentration of Cefuroxime can be decreased when it is combined with Magnesium peroxide. |
| Chloroquine | Magnesium peroxide can cause a decrease in the absorption of Chloroquine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Elvitegravir | Magnesium peroxide can cause a decrease in the absorption of Elvitegravir resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Gabapentin enacarbil | The serum concentration of Gabapentin enacarbil can be decreased when it is combined with Magnesium peroxide. |
| Hyoscyamine | Magnesium peroxide can cause a decrease in the absorption of Hyoscyamine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Rifampin | Magnesium peroxide can cause a decrease in the absorption of Rifampicin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Mecamylamine | Magnesium peroxide may decrease the excretion rate of Mecamylamine which could result in a higher serum level. |
| Memantine | Magnesium peroxide may decrease the excretion rate of Memantine which could result in a higher serum level. |
| Penicillamine | Magnesium peroxide can cause a decrease in the absorption of Penicillamine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Quinidine | Magnesium peroxide may decrease the excretion rate of Quinidine which could result in a higher serum level. |
| Quinine | Magnesium peroxide can cause a decrease in the absorption of Quinine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Sotalol | The serum concentration of Sotalol can be decreased when it is combined with Magnesium peroxide. |
| Sulpiride | The therapeutic efficacy of Sulpiride can be increased when used in combination with Magnesium peroxide. |
| Deferasirox | Magnesium peroxide can cause a decrease in the absorption of Deferasirox resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Allopurinol | The therapeutic efficacy of Allopurinol can be decreased when used in combination with Magnesium peroxide. |
| Fexofenadine | Magnesium peroxide can cause a decrease in the absorption of Fexofenadine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Raltegravir | Magnesium peroxide can cause a decrease in the absorption of Raltegravir resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Halofantrine | Magnesium peroxide can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Misoprostol | The risk or severity of adverse effects can be increased when Magnesium peroxide is combined with Misoprostol. |
| Mesalazine | Magnesium peroxide can cause a decrease in the absorption of Mesalazine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Mycophenolic acid | The serum concentration of Mycophenolic acid can be decreased when it is combined with Magnesium peroxide. |
| Cysteamine | The bioavailability of Cysteamine can be decreased when combined with Magnesium peroxide. |
| Ketoconazole | Magnesium peroxide can cause a decrease in the absorption of Ketoconazole resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Tramadol | The therapeutic efficacy of Magnesium peroxide can be decreased when used in combination with Tramadol. |
| Trospium | The therapeutic efficacy of Magnesium peroxide can be decreased when used in combination with Trospium. |
| Oxyphenonium | The therapeutic efficacy of Magnesium peroxide can be decreased when used in combination with Oxyphenonium. |
| Benzatropine | The therapeutic efficacy of Magnesium peroxide can be decreased when used in combination with Benzatropine. |
| Ziprasidone | The therapeutic efficacy of Magnesium peroxide can be decreased when used in combination with Ziprasidone. |
| Disopyramide | The therapeutic efficacy of Magnesium peroxide can be decreased when used in combination with Disopyramide. |
| Amitriptyline | The therapeutic efficacy of Magnesium peroxide can be decreased when used in combination with Amitriptyline. |
| Ipratropium | The therapeutic efficacy of Magnesium peroxide can be decreased when used in combination with Ipratropium. |
| Olanzapine | The therapeutic efficacy of Magnesium peroxide can be decreased when used in combination with Olanzapine. |
| Metixene | The therapeutic efficacy of Magnesium peroxide can be decreased when used in combination with Metixene. |
| Terfenadine | The therapeutic efficacy of Magnesium peroxide can be decreased when used in combination with Terfenadine. |
| Buclizine | The therapeutic efficacy of Magnesium peroxide can be decreased when used in combination with Buclizine. |
| Clozapine | The therapeutic efficacy of Magnesium peroxide can be decreased when used in combination with Clozapine. |
| Doxylamine | The therapeutic efficacy of Magnesium peroxide can be decreased when used in combination with Doxylamine. |
| Trihexyphenidyl | The therapeutic efficacy of Magnesium peroxide can be decreased when used in combination with Trihexyphenidyl. |
| Oxyphencyclimine | The therapeutic efficacy of Magnesium peroxide can be decreased when used in combination with Oxyphencyclimine. |
| Procyclidine | The therapeutic efficacy of Magnesium peroxide can be decreased when used in combination with Procyclidine. |
| Profenamine | The therapeutic efficacy of Magnesium peroxide can be decreased when used in combination with Profenamine. |
| Cyproheptadine | The therapeutic efficacy of Magnesium peroxide can be decreased when used in combination with Cyproheptadine. |
| Imipramine | The therapeutic efficacy of Magnesium peroxide can be decreased when used in combination with Imipramine. |
| Methscopolamine bromide | The therapeutic efficacy of Magnesium peroxide can be decreased when used in combination with Methscopolamine bromide. |
| Gallamine triethiodide | The therapeutic efficacy of Magnesium peroxide can be decreased when used in combination with Gallamine triethiodide. |
| Darifenacin | The therapeutic efficacy of Magnesium peroxide can be decreased when used in combination with Darifenacin. |
| Tridihexethyl | The therapeutic efficacy of Magnesium peroxide can be decreased when used in combination with Tridihexethyl. |
| Anisotropine methylbromide | The therapeutic efficacy of Magnesium peroxide can be decreased when used in combination with Anisotropine methylbromide. |
| Nortriptyline | The therapeutic efficacy of Magnesium peroxide can be decreased when used in combination with Nortriptyline. |
| Amoxapine | The therapeutic efficacy of Magnesium peroxide can be decreased when used in combination with Amoxapine. |
| Atropine | The therapeutic efficacy of Magnesium peroxide can be decreased when used in combination with Atropine. |
| Pirenzepine | The therapeutic efficacy of Magnesium peroxide can be decreased when used in combination with Pirenzepine. |
| Paroxetine | The therapeutic efficacy of Magnesium peroxide can be decreased when used in combination with Paroxetine. |
| Homatropine methylbromide | The therapeutic efficacy of Magnesium peroxide can be decreased when used in combination with Homatropine methylbromide. |
| Rocuronium | The therapeutic efficacy of Magnesium peroxide can be decreased when used in combination with Rocuronium. |
| Scopolamine | The therapeutic efficacy of Magnesium peroxide can be decreased when used in combination with Scopolamine. |
| Benzquinamide | The therapeutic efficacy of Magnesium peroxide can be decreased when used in combination with Benzquinamide. |
| Clidinium | The therapeutic efficacy of Magnesium peroxide can be decreased when used in combination with Clidinium. |
| Propiomazine | The therapeutic efficacy of Magnesium peroxide can be decreased when used in combination with Propiomazine. |
| Propantheline | The therapeutic efficacy of Magnesium peroxide can be decreased when used in combination with Propantheline. |